SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-068056
Filing Date
2018-03-02
Accepted
2018-03-02 07:02:33
Documents
3
Period of Report
2018-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d545895d8k.htm 8-K 16869
2 EX-99.1 d545895dex991.htm EX-99.1 8209
3 GRAPHIC g545895g0301000620178.jpg GRAPHIC 4503
  Complete submission text file 0001193125-18-068056.txt   32955
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 18659965
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services